Related Experiment Video
Updated: May 3, 2026
09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.7K
Interventions for Long COVID: A Narrative Review
Ilya Ivlev1,2, Jesse Wagner3, Taylor Phillips3
1ECRI, 5200 Butler Pike, Plymouth Meeting, PA, 19462, USA. ivlev@ohsu.edu.
Journal of General Internal Medicine
|February 21, 2025
Summary
Evidence for long COVID treatments is weak, with significant uncertainty about benefits and harms. More rigorous research is crucial for effective long COVID management strategies.
Area of Science:
- Medical Research
- Public Health
- Clinical Medicine
Background:
- Long COVID presents diverse symptoms and clinical uncertainty for survivors.
- Managing long COVID symptoms like fatigue, neurocognitive issues, anxiety, depression, and sleep disturbances remains challenging.
Purpose of the Study:
- To synthesize evidence on the effectiveness, comparative effectiveness, and risks of interventions for common long COVID symptoms.
- To identify barriers to care and needs for future research in long COVID management.
Main Methods:
- Systematic review of 97 studies (26 RCTs, 15 non-randomized comparative studies).
- Inclusion of English articles, gray literature, and input from 14 key informants (patients, caregivers, clinicians, payors, researchers).
- Analysis of interventions including rehabilitation, supplements, complementary treatments, medications, and COVID-19 vaccination.
Main Results:
- The body of evidence for long COVID interventions is persistently weak, with high imprecision and uncertainty regarding benefits and harms.
- Key informants highlighted the need for diagnostic criteria, functional outcomes, and addressed barriers like dismissive attitudes and inadequate insurance coverage.
- Many patients resort to self-treatment with potentially ineffective and costly options due to treatment uncertainty.
Conclusions:
- There is a pressing need for more rigorous research to validate effective long COVID treatment protocols.
- Clinicians and patients face substantial uncertainty in treatment decisions due to the evolving nature of long COVID and its management.
- Addressing healthcare system barriers is essential for improving care for long COVID survivors.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.4K
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33